![A woman washes her face](https://www.uc.edu/news/articles/2024/03/n21234626/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1710341378668.jpg)
The Cut: Can my acne products cause cancer?
The University of Cincinnati's Kelly Dobos spoke with The Cut about the risk of benzene exposure in common acne products.
Recently, an independent laboratory filed a petition with the Food and Drug Administration requesting the recall of products that contain an over-the-counter acne-treating drug called benzoyl peroxide due to elevated levels of the carcinogen benzene.
“Unless someone is keeping their acne treatment in a car during the hottest days of summer, it’s incredibly unlikely your product will experience that kind of condition" of increased benzene exposure, Dobos, a cosmetic chemist and adjunct instructor in UC's Cosmetic Science Program in the James L. Winkle College of Pharmacy, told The Cut.
Dobos noted most people are exposed to at least some level of benzene every day, regardless of the acne products they use. People can experience elevated levels when cooking over a gas flame, putting fuel in your car or sitting next to a person who is vaping or smoking.
“According to information from the World Health Organization, outdoor air has a background benzene level ranging from 0.31 parts per billion in rural areas to 1.5 to 2.3 parts per billion in suburbs and cities," she said.
Featured photo at top of a woman washing her face. Photo/Extreme Photographer/iStock.
Related Stories
Discover Magazine: Why bacteria are the new disease fighters
January 10, 2022
UC's Dr. Nalinikanth Kotagiri was featured in a Discover Magazine article focused on the use of bacteria to fight diseases including cancer.
Journal-News: UC researchers engineer bacteria to weaken cancer cell walls
November 22, 2021
University of Cincinnati researchers from the College of Pharmacy were featured in a Journal-News article detailing the development of a new probiotic bacteria designed to break down cancer cell walls.
Law & Crime: Medical uses and dosages of fentanyl
February 23, 2022
The University of Cincinnati's Dr. Dan Arendt was featured in a Law & Crime television segment on the topic of medical uses of fentanyl.
55KRC: Grants aid UC research of pediatric brain tumors
March 14, 2022
55KRC featured the University of Cincinnati's Dr. Timothy Phoenix on the Simply Medicine program, discussing his research into treatments for diffuse midline glioma, a deadly pediatric brain tumor.
Medical Xpress: Researchers identify new target to treat pediatric brain tumors
February 4, 2022
Medical Xpress highlighted the work of the University of Cincinnati's Timothy Phoenix and his colleagues who have identified the role of a key gene linked to pediatric diffuse midline gliomas, a deadly brain tumor.
HuffPost: Things you didn't know pharmacists could help with
March 23, 2022
The University of Cincinnati's Michael Hegener, PharmD, was featured in a HuffPost article about different health issues pharmacists can help patients with beyond filling prescriptions.
Local 12: Pharmacies adjusting hours due to staffing issues
April 29, 2022
The University of Cincinnati's Jill Boone was featured in a Local 12 story on the impact of staffing issues at local pharmacies.
WVXU: Exploring the under-regulated dietary supplements industry
August 17, 2022
The University of Cincinnati's Michael Hegener, PharmD, was a panelist on WVXU's Cincinnati Edition discussing the under-regulated dietary supplements industry.
Drug Discovery News: Silence in healthy cells makes FOXR2 a potential cancer target
April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.
Physics World: Engineered bacteria attract cancer-killing radioisotopes into tumors
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.